Advanced Medical Solutions Group (LSE:AMS) 3-Year Book Growth Rate : 6.70% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Advanced Medical Solutions Group 3-Year Book Growth Rate?

Advanced Medical Solutions Group's Book Value per Share for the quarter that ended in Dec. 2023 was £1.14.

During the past 12 months, Advanced Medical Solutions Group's average Book Value per Share Growth Rate was 4.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 6.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was 7.00% per year. During the past 10 years, the average Book Value per Share Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Advanced Medical Solutions Group was 36.70% per year. The lowest was -16.80% per year. And the median was 10.70% per year.

Competitive Comparison of Advanced Medical Solutions Group's 3-Year Book Growth Rate

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Medical Solutions Group's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's 3-Year Book Growth Rate falls into.

Advanced Medical Solutions Group 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Advanced Medical Solutions Group (LSE:AMS) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Advanced Medical Solutions Group 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Medical Solutions Group (LSE:AMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (LSE:AMS) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

AMS.GB:UK AQA:Germany

Address

Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT

Website

https://www.admedsol.com

U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.